Clinical Trials Directory

Trials / Unknown

UnknownNCT05603390

Heart Failure With Mildly Reduced Ejection Fraction Registry

Heart Failure With Mildly Reduced Ejection Fraction Registry (HARMER)

Status
Unknown
Phase
Study type
Observational
Enrollment
2,200 (estimated)
Sponsor
Universitätsmedizin Mannheim · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart failure (HF) affects about 1% of patients younger than 55 years, whereas the prevalence of HF increases \> 10% in patients with at least 70 years of age. Despite HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the clinical significance of HF with mildly reduced ejection fraction (HFmrEF) has gained more importance within the past years. Those patients are characterized by a left ventricular ejection fraction (LVEF) of 41-49%. However, within the current European guidelines, limited treatment recommendations in this subgroup of HF are yet available as a consequence of the limited number of studies in this field. The "Heart Failure With Mildly Reduced Ejection Fraction Registry" aims to characterize patients with HFmrEF and investigated the prognostic impact of interventional and pharmacological therapies in this subgroup of HF patients.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2022-01-01
Completion
2023-01-01
First posted
2022-11-02
Last updated
2022-11-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05603390. Inclusion in this directory is not an endorsement.